Signaling pathways
-
BA7814 GSK360ASummary: GSK360A is an orally active inhibitor with values of 10, 100 and 126 nM for PHD1, PHD2 and PHD3, respectively. - BA7815 HIF-PHD-IN-1Summary: HIF-PHD-IN-1 is an orally active inhibitor of the structural domain of the hypoxia-inducible factor prolyl hydroxylase.
- BA7816 ZINC13466751Summary: ZINC13466751 is a potent inhibitor of the interaction.
- BA7817 HIF-1α-IN-5Summary: HIF-1α-IN-5 is an inhibitor.
- BA7818 HIF-2α-IN-3Summary: HIF-2α-IN-3 is a variant inhibitor.
- BA7819 TM6089Summary: TM6089 is a unique inhibitor that stimulates activity without iron chelation, induces angiogenesis and exerts a protective effect on ischemic organs.
- BA7820 VelutinSummary: Velutin is a glycoside extracted from enoki mushrooms with melanin biosynthesis inhibiting activity.
- BA7821 PHD-1-IN-1Summary: PHD-1-IN-1 is an orally active, potent structural domain 1 inhibitor of the hypoxia-inducible factor prolyl hydroxylase.
- BA7822 HIF-1α-IN-4Summary: HIF-1α-IN-4 is an inhibitor.
- BA7823 TRC160334Summary: TRC160334 is an inhibitor.